logo-loader
viewMidatech Pharma PLC

Riccardo Lowi discusses Midatech Pharma PLC

Riccardo Lowi talks through Midatech Pharma PLC and how the company is addressing high unmet need in cancer markets.

Quick facts: Midatech Pharma PLC

Price: - -

AIM:MTPH
Market: AIM
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Midatech Pharma PLC named herein, including the promotion by the Company of Midatech Pharma PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Midatech Pharma Plc 'very excited' to take GNP technology into trials

Midatech Pharma (LON:MTPH Nasdaq:MTP) is to take its gold-plated nanoparticle technology forward into trials as a treatment for advanced liver cancer. Chief executive Jim Phillips tells Proactive: ''This is the first time that we've been able to advance a targeted chemotherapy in a way...

on 11/15/2016

2 min read